33899829|t|[Delirium in the "young" covid-19 patient (<65 years): preliminary clinical indications].
33899829|a|Delirium is a phenomenon classified within neuro-cognitive disorders in the DSM-5. It has several etiologies and it is often lethal. This contribute aims at analyzing clinical characteristics and diagnostic possibilities of delirium in patients affected by covid-19. Furthermore, some preliminary recommendations on the use of psychopharmacological treatment of delirium and their interactions with main drugs used to treat covid-19 are given, with a special attention to comorbidities like in immunocompromised patients, in those affected by diabetes and cancer, in pregnant women or in addicted clients.
33899829	1	9	Delirium	Disease	MESH:D003693
33899829	25	33	covid-19	Disease	MESH:D000086382
33899829	34	41	patient	Species	9606
33899829	90	98	Delirium	Disease	MESH:D003693
33899829	133	158	neuro-cognitive disorders	Disease	MESH:D003072
33899829	314	322	delirium	Disease	MESH:D003693
33899829	326	334	patients	Species	9606
33899829	347	355	covid-19	Disease	MESH:D000086382
33899829	452	460	delirium	Disease	MESH:D003693
33899829	514	522	covid-19	Disease	MESH:D000086382
33899829	602	610	patients	Species	9606
33899829	633	641	diabetes	Disease	MESH:D003920
33899829	646	652	cancer	Disease	MESH:D009369
33899829	666	671	women	Species	9606

